InMed Pharmaceuticals Ownership | Who Owns InMed Pharmaceuticals?

InMed Pharmaceuticals Ownership Summary

InMed Pharmaceuticals is owned by 0.34% insiders, and 99.66% retail investors. AdvisorShares Pure Cannabis ETF is the top mutual fund, with 1.36% of its assets in InMed Pharmaceuticals shares.

INM Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	InMed Pharmaceuticals	-	0.34%	99.66%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Biotech Stocks	35.43%	12.01%	52.56%

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	1	-91.67%	27	-100.00%	-	-	-	-100.00%	-	-100.00%
Sep 30, 2024	11	-8.33%	1,113,450	152.90%	-	0.86%	7	75.00%	1	-66.67%
Jun 30, 2024	12	-25.00%	440,278	-35.81%	4	6.19%	4	-20.00%	3	-
Mar 31, 2024	16	6.67%	685,866	-14.72%	8	8.45%	5	-44.44%	3	50.00%
Dec 31, 2023	15	66.67%	804,250	2893.45%	10	837.71%	9	50.00%	2	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
AdvisorShares Pure Cannabis ETF	16.43K	1.36%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 15, 2026	ADAR1 Capital Management, LLC	-	Buy	$1.55K
Jul 16, 2026	Vivo Opportunity, LLC	-	Buy	$3.10
Jul 16, 2026	Vivo Opportunity, LLC	-	Buy	$29.45
Jul 15, 2026	Vivo Opportunity, LLC	-	Buy	$21.33K
Jul 14, 2026	Vivo Opportunity, LLC	-	Buy	$7.57K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	11	-
2026 Q2	23	-
2025 Q4	-	-
2025 Q1	-	-
2024 Q4	-	-

INM Ownership FAQ

Who Owns InMed Pharmaceuticals?

InMed Pharmaceuticals shareholders are primarily institutional investors at 0%, followed by 0.34% insiders and 0% retail investors. The average institutional ownership in InMed Pharmaceuticals's industry, Biotech Stocks , is 35.43%, which InMed Pharmaceuticals falls below.

Does Blackrock own InMed Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of InMed Pharmaceuticals.

Who is the top mutual fund holder of InMed Pharmaceuticals shares?

AdvisorShares Pure Cannabis ETF is the top mutual fund holder of InMed Pharmaceuticals shares, with 1.36% of its total shares outstanding invested in 16.43K InMed Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools